Treatment with the monoclonal calcitonin gene‐related peptide receptor antibody erenumab: A real‐life study

BACKGROUND AND PURPOSE: New prophylactics for migraine, targeting calcitonin gene‐related peptide (CGRP), have recently emerged. Real‐world data are important for a comprehensive understanding of treatment response. We assessed the consistency of response to erenumab, a monoclonal CGRP receptor anti...

Descripción completa

Detalles Bibliográficos
Autores principales: de Vries Lentsch, Simone, Verhagen, Iris E., van den Hoek, Thomas C., MaassenVanDenBrink, Antoinette, Terwindt, Gisela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Headache
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291504/
https://www.ncbi.nlm.nih.gov/pubmed/34424593
http://dx.doi.org/10.1111/ene.15075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291504/
https://www.ncbi.nlm.nih.gov/pubmed/34424593
http://dx.doi.org/10.1111/ene.15075

Ejemplares similares